These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 1531361
1. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles. Ogletree ML, Allen GT. J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361 [Abstract] [Full Text] [Related]
2. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552. Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM. J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833 [Abstract] [Full Text] [Related]
3. Characterization of thromboxane A2/prostaglandin endoperoxide receptors in aorta. Zhang R, Ogletree ML, Moreland S. Eur J Pharmacol; 1996 Dec 12; 317(1):91-6. PubMed ID: 8982724 [Abstract] [Full Text] [Related]
12. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. Dorn GW, Becker MW, Davis MG. J Biol Chem; 1992 Dec 05; 267(34):24897-905. PubMed ID: 1447225 [Abstract] [Full Text] [Related]
13. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. Ogletree ML, Harris DN, Greenberg R, Haslanger MF, Nakane M. J Pharmacol Exp Ther; 1985 Aug 05; 234(2):435-41. PubMed ID: 3926986 [Abstract] [Full Text] [Related]
14. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist. Bertolino F, Valentin JP, Maffre M, Jover B, Bessac AM, John GW. J Pharmacol Exp Ther; 1994 Feb 05; 268(2):747-52. PubMed ID: 8113986 [Abstract] [Full Text] [Related]
15. Thromboxane binding and signal transduction in rat glomerular mesangial cells. Spurney RF, Onorato JJ, Albers FJ, Coffman TM. Am J Physiol; 1993 Feb 05; 264(2 Pt 2):F292-9. PubMed ID: 8447439 [Abstract] [Full Text] [Related]
16. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells. Miki I, Kase H, Ishii A. Eur J Pharmacol; 1992 Oct 01; 227(2):199-204. PubMed ID: 1426029 [Abstract] [Full Text] [Related]
17. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements. Tymkewycz PM, Jones RL, Wilson NH, Marr CG. Br J Pharmacol; 1991 Mar 01; 102(3):607-14. PubMed ID: 1364826 [Abstract] [Full Text] [Related]
18. Role of thromboxane A2 in bradykinin-induced human isolated small bronchi contraction. Molimard M, Martin CA, Naline E, Hirsch A, Advenier C. Eur J Pharmacol; 1995 May 04; 278(1):49-54. PubMed ID: 7545124 [Abstract] [Full Text] [Related]
19. Effects of thromboxane A2 on thoracic aorta of young and old rats: use of selective thromboxane receptor antagonists. Shams G, Wallace LJ, Miller DD, Feller DR. Pharmacology; 1990 May 04; 40(1):27-32. PubMed ID: 2139513 [Abstract] [Full Text] [Related]
20. Thromboxane A2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity. Cao J, Wakatsuki A, Yoshida M, Kitazawa T, Taneike T. Eur J Pharmacol; 2004 Feb 06; 485(1-3):317-27. PubMed ID: 14757156 [Abstract] [Full Text] [Related] Page: [Next] [New Search]